At a glance
- Originator Teijin Pharma
- Class Benzoic acids
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma
Most Recent Events
- 19 Oct 2000 Discontinued-Preclinical for Allergic asthma in Japan (Unknown route)
- 14 Sep 1999 Preclinical development for Allergic asthma in Japan (Unknown route)